| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 03/29/2005 | US6872389 Which differentiate into hepatocytes; comprise cytokeratin markers |
| 03/29/2005 | US6872387 Mixing alginate salt, calcium carbonate, and d-gluconolactone, crosslinking to form hydrogel, and controlling shrinking/ swelling; for scaffolds for the support of cells; solid phase synthesis; organ/tissue engineering; osteoblasts |
| 03/29/2005 | US6872385 Adjuvant preparation for the induction of specific immunity |
| 03/29/2005 | CA2323506C Mammalian blood loss-induced gene, kd312 |
| 03/29/2005 | CA2137271C Apparatus for obtaining a supernatant of activited thrombocytes, process for said apparatus and supernatant thereof |
| 03/24/2005 | WO2005026718A1 Stem cell libraries |
| 03/24/2005 | WO2005026382A1 Neural colony forming assay |
| 03/24/2005 | WO2005026343A1 Method of promoting subsistence and/or proliferation of neural stem cell and promoting extension of neurite, promoter therefor, pharmaceutical composition containing neural stem cell, method of assay and method of screening |
| 03/24/2005 | WO2005026336A1 Monoclonal antibody specific for ppar gamma, hybridoma cell line producing the same, and method for detecting regulator related to diseases, including inflammation, cancer and metabolic diseases, using the same |
| 03/24/2005 | WO2005026335A2 Insulin-producing bone marrow derived cells and methods of generating and using same |
| 03/24/2005 | WO2005026334A2 Human tumour growth patterns |
| 03/24/2005 | WO2005026332A1 Generation of human embryonic stem cells from triploid zygotes |
| 03/24/2005 | WO2005026330A1 Matrix derived from whole organ |
| 03/24/2005 | WO2005026328A2 Cpt resistant cell line |
| 03/24/2005 | WO2005026326A2 Generation of chicken cell lines from embryonic stem cells and germ cells |
| 03/24/2005 | WO2005026324A2 Method and composition for enhancing in vitro embryo development by supplementing culture medium with prostaglandin or a prostaglandin analog |
| 03/24/2005 | WO2005026320A2 Entrapped stem cells and uses thereof |
| 03/24/2005 | WO2005026319A2 Erythrocytic cells and method for loading solutes |
| 03/24/2005 | WO2005026318A2 Methods and compositions for producing antigenic responses |
| 03/24/2005 | WO2005026313A1 Methods and device for adhesive control of internal cell organisation |
| 03/24/2005 | WO2005026209A2 Monoclonal antibodies against hmgb1 |
| 03/24/2005 | WO2005026201A1 Immortalisation of mammalian cells and therapeutic applications of said cells |
| 03/24/2005 | WO2005025584A1 Use of adipose tissue cells for initiating the formation of a functional vascular network |
| 03/24/2005 | WO2005025538A1 Composition for medical use containing sugar chain-containing chitosan derivative and glycosaminoglycan |
| 03/24/2005 | WO2005025517A2 Animal model for protease activity and liver damage |
| 03/24/2005 | WO2005025494A2 Vaccine immunotherapy for immune suppressed patients |
| 03/24/2005 | WO2005025493A2 Biological engineering of articular structures containing both cartilage and bone |
| 03/24/2005 | WO2005010172A3 Aligned scaffolds for improved myocardial regeneration |
| 03/24/2005 | WO2005003297A3 Mptens as modifiers of the pten/igf pathway and methods of use |
| 03/24/2005 | WO2005003286A8 Culture control apparatus for cell or tissue and method thereof |
| 03/24/2005 | WO2005001087A3 Methods of modifying genes in eukaryotic cells |
| 03/24/2005 | WO2005001080A3 Postpartum-derived cells for use in treatment of disease of the heart and circulatory system |
| 03/24/2005 | WO2005001026A3 Adks as modifiers of the pten pathway and methods of use |
| 03/24/2005 | WO2004111194A3 Method to increase protein production in culture |
| 03/24/2005 | WO2004108893A3 Cell specific replication-competent viral vectors comprising a self processing peptide cleavage site |
| 03/24/2005 | WO2004101766A3 Grp94-based compositions and methods of use thereof |
| 03/24/2005 | WO2004092322A3 Devices and assays for monitoring/measuring cellular dynamics to create subject profiles from primary cells |
| 03/24/2005 | WO2004087860A3 Materials and methods for regulating process formation in cell culture |
| 03/24/2005 | WO2004085631A3 Canine embryonic stem cells |
| 03/24/2005 | WO2004072262A3 Cultured cd14+ antigen presenting cells |
| 03/24/2005 | WO2004068931A3 Amphiregulin antibodies and their use to treat cancer and psoriasis |
| 03/24/2005 | WO2004056309A3 Neuroprotective activity of activated protein c is independent of its anticoagulant activity |
| 03/24/2005 | WO2004047731A3 Modulation of notch3 expression |
| 03/24/2005 | WO2004043338A3 Flavin n-oxides: new anti-cancer agents and pathogen eradication agents |
| 03/24/2005 | WO2004033635A3 Retinal pigment epithelial cell cultures on amniotic membrane and transplantation |
| 03/24/2005 | WO2004017972A8 Biologic skin repair and enhancement |
| 03/24/2005 | WO2004014955A9 Anti-idiotypic antibodies against factor viii inhibitor and uses thereof |
| 03/24/2005 | WO2003087134A3 G-protein coupled receptor ligands and methods |
| 03/24/2005 | WO2003072746A3 Subtilisin carlsberg proteins with reduced immunogenicity |
| 03/24/2005 | WO2003062380A3 Multiply-substituted protease variants |
| 03/24/2005 | WO2002092759A9 Molecules for disease detection and treatment |
| 03/24/2005 | US20050066392 Expression vector comprising nucleotide sequences coding which confer a tolerant phenotype in plants in response to chronic and/or acute inhibitin dosages of auxinic herbicides |
| 03/24/2005 | US20050066384 Using plasmid to enhance site-specific and/or homologous recombination between heterologous gene sequences and host nuclear DNA; tissue engineering and exogenous gene expression in plants |
| 03/24/2005 | US20050066379 Preparing somatic embryo by utilizing rabbit oocyte |
| 03/24/2005 | US20050065328 Gastrokines and derived peptides including inhibitors |
| 03/24/2005 | US20050065321 Cytokine receptor (Zcytor16) for use as tool in prevention and treatment of cell proliferative and nervous system disorders |
| 03/24/2005 | US20050065107 Plasmids suitable for IL-2 expression |
| 03/24/2005 | US20050065093 Inhibitors of the ICE/ced-3 family of cysteine proteases |
| 03/24/2005 | US20050065084 polynucleotide codes for saratin polypeptides from saliva of leeches, used as antagonist for collagen-dependent platelet adhesion; genetic engineering; prophylaxis of cardiovascular disorders |
| 03/24/2005 | US20050065079 Therapy for metabolism disorders ; obesity; antilipemic agents; atherosclerosis; hypotensive agents; antidiabetic agents |
| 03/24/2005 | US20050064594 Transgenic liver cell for use as tool in diagnosis, prevention and treatment of viral diseases; viricides and receptor binding activity |
| 03/24/2005 | US20050064593 Expression vector comprising breast cancer gene (BCL-2) nucleotide sequences for use as tool in treatment, diagnosis and prevention of cell proliferative disorders |
| 03/24/2005 | US20050064591 Washing heart tissue in alcohol, water and glycosidase to remove carbohydrate moieties in preparation of engraftment in human; tissue repair and engineering; transplantation |
| 03/24/2005 | US20050064589 Blastocyst culture media |
| 03/24/2005 | US20050064588 Epidermal melanocyte culture formulations |
| 03/24/2005 | US20050064587 Pancreatic small cells and uses thereof |
| 03/24/2005 | US20050064586 Somatic cell derived embryonic stem cells and its differentiated cells |
| 03/24/2005 | US20050064578 Multicompartment apparatus for use in transfection of nucleic acids into cells; electrofusion; electroporation |
| 03/24/2005 | US20050064572 Lipid kinase |
| 03/24/2005 | US20050064570 Whole cell catalyst which expresses lactobacillus oxidase for use in generating/producing chrial enantiomer-enriched organic compounds |
| 03/24/2005 | US20050064558 Chimeric polypeptide comprising functional differentially spliced interleukin receptor and b-cell differentiation factor for enhancing expression of interferon inducible protein (IP-10) and macrophage inflammarory proteins for use in treatment of viral diseases |
| 03/24/2005 | US20050064546 Production of recombinant lactoferrin and lactoferrin polypeptides using cDNA sequences in various organisms |
| 03/24/2005 | US20050064544 Nucleotide sequences coding kinase for use as tool in identifying modulator for treatment and prevention of respiratory, cell proliferative, prostate, mammary gland and muscle disorders |
| 03/24/2005 | US20050064543 Secreted proteins |
| 03/24/2005 | US20050064533 Asparagine hydroxylation of the cad domain of a hif protein |
| 03/24/2005 | US20050064530 Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor |
| 03/24/2005 | US20050064524 Cell for use as tools in analyte detection; biosensor for screening quality of food and water |
| 03/24/2005 | US20050064521 Three dimensional matrix/model for monitoring effect of pro- and anti-angiogenic compounds on cell propagation; tissue enegineering; regenerative medicine |
| 03/24/2005 | US20050064518 Monoclonal antibody for use in prevention and treatment of ovarian cancer; immunotherapeutics |
| 03/24/2005 | US20050064493 Antibodies specific for vascular endothelial growth factor-B and DNA coding therefor |
| 03/24/2005 | US20050064491 Transport protein for use as tool in identifying modulator for treatment of sleep, nervous suystem, anixety, eating, cardiovascular and pain disordere |
| 03/24/2005 | US20050064475 Using type II membrane glycoprotein (4F2hc) as tool in identifying modulator which inhibit transcription in tumor cells; gene expresion inhibition and antitumors agents |
| 03/24/2005 | US20050064458 Nucleotide sequences coding membrane protein for use in diagnosis, prevention and treatnment of cell proliferative, nervous system, metabolic and inflammatory disorders |
| 03/24/2005 | US20050064445 Serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 03/24/2005 | US20050064443 Production of functional proteins: balance of shear stress and gravity |
| 03/24/2005 | US20050064440 Using single nucleotide polymorphism in contactin-2 (CNTN-2) and kinesin-7 (CENP-E) genes as diagnostic indicators of cell proliferative disorders; antitumor agents; ribozymes and tumor treatment; RNA interference |
| 03/24/2005 | US20050064420 Expression vector comprising nucleotide sequences coding estrogen response element for use as regulatory tool in heterologous gene expression |
| 03/24/2005 | US20050064416 Methods for diagnosing and treating heart disease |
| 03/24/2005 | US20050064404 Regulation of human serotonin-like g protein-coupled receptor |
| 03/24/2005 | US20050064390 Transgenic cell line expressing chemokine receptor for use as model in identifying modulators wich prevent/block viral infection; viricides |
| 03/24/2005 | US20050064041 Continuous exchange of a predetermined volume of a demineralizing acid solution; use in tissue repair of bone; faster, less damaging to the osteoinductive properties |
| 03/24/2005 | US20050063995 mammalian tumor cells having been treated ex vivo by stressing with an oxidative environment such as ozone or oxygen and UV light simultaneously, to render the tumor cells effective to elicit an immune response to a melanoma, colon carcinoma or breast cancer tumor |
| 03/24/2005 | US20050063993 For treatment of cancer/tumors/fungal/viral infections; tumor associated antigens; genetic engineering |
| 03/24/2005 | US20050063982 GRP94-based compositions and methods of use thereof |
| 03/24/2005 | US20050063977 Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (SCLC) |
| 03/24/2005 | US20050063971 Monoclonal or humanized antibodies that immunospecifically bind to FGF-CX or any derivative, variant, mutant, polypeptide fragment, polynucleotide or antibody |
| 03/24/2005 | US20050063970 An immunomolecule containing a soluble human Major Histocompatibility Complex class I effector domain linked to an antibody targeting domain; immunotherapy; anticarcinogenic agents |
| 03/24/2005 | US20050063962 Use of polarized light microscopy for visualization of the spindle body of a cell in metaphase during cell enucleation with minimal amount of cytoplasm; totipotent or pluripotent cells; cloned vertebrates |
| 03/24/2005 | US20050063961 Hematopoietic stem cells and endothelial progenitor cells; express the cell surface antigen CD31; delivering transgenes to the eye for cell-based gene therapy; treating ocular diseases such as retinopathy |
| 03/24/2005 | US20050063960 Dna construct for assessing thymic function activity and therapeutical uses thereof |